PL2105129T3 - Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt - Google Patents

Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt

Info

Publication number
PL2105129T3
PL2105129T3 PL09156077T PL09156077T PL2105129T3 PL 2105129 T3 PL2105129 T3 PL 2105129T3 PL 09156077 T PL09156077 T PL 09156077T PL 09156077 T PL09156077 T PL 09156077T PL 2105129 T3 PL2105129 T3 PL 2105129T3
Authority
PL
Poland
Prior art keywords
boostering
fish
animals
oral vaccination
encapsulated vaccines
Prior art date
Application number
PL09156077T
Other languages
English (en)
Inventor
Moti Harel
Original Assignee
Intervet International B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International B.V. filed Critical Intervet International B.V.
Publication of PL2105129T3 publication Critical patent/PL2105129T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pulmonology (AREA)
  • Insects & Arthropods (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
PL09156077T 2008-03-24 2009-03-24 Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt PL2105129T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3880908P 2008-03-24 2008-03-24
EP09156077.1A EP2105129B1 (en) 2008-03-24 2009-03-24 Encapsulated Vaccines for the Oral Vaccination and Boostering of Fish and Other Animals

Publications (1)

Publication Number Publication Date
PL2105129T3 true PL2105129T3 (pl) 2018-04-30

Family

ID=40707755

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09156077T PL2105129T3 (pl) 2008-03-24 2009-03-24 Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt

Country Status (6)

Country Link
US (2) US7998502B2 (pl)
EP (1) EP2105129B1 (pl)
CA (1) CA2659917C (pl)
ES (1) ES2661038T3 (pl)
NO (1) NO2105129T3 (pl)
PL (1) PL2105129T3 (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097245B2 (en) 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8460726B2 (en) 2006-12-18 2013-06-11 Advanced Bionutrition Corporation Dry food product containing live probiotic
US8778384B2 (en) 2008-03-24 2014-07-15 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
PL2105129T3 (pl) * 2008-03-24 2018-04-30 Intervet International B.V. Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt
WO2010111565A2 (en) * 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
ES2649112T3 (es) 2009-05-18 2018-01-10 Sigmoid Pharma Limited Composición que comprende gotas de aceite
WO2010138522A2 (en) 2009-05-26 2010-12-02 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
CN107582526A (zh) * 2009-08-12 2018-01-16 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
US8834951B2 (en) 2010-01-28 2014-09-16 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
WO2012021783A2 (en) 2010-08-13 2012-02-16 Advanced Bionutrition Corporation Dry storage stabilizing composition for biological materials
US9345760B2 (en) 2011-09-09 2016-05-24 Advanced Bionutrition Corporation IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same
RU2014132761A (ru) 2012-02-21 2016-04-10 Эдванст Бионутришн Корпорейшн Композиции и способы целевой доставки биологически активного агента водным организмам
US9486516B2 (en) 2012-03-22 2016-11-08 Bioorganic Research And Services Sa Formulations for non-invasive delivery of active proteins to an animal or human
CA2783146C (en) * 2012-05-08 2020-04-07 Intervet International B.V. Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
GB201212010D0 (en) * 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CN113750075A (zh) 2013-12-06 2021-12-07 英特维特国际股份有限公司 用于经口递送生物活性剂的组合物
EP3881829A1 (en) 2014-11-07 2021-09-22 Sublimity Therapeutics Limited Compositions comprising cyclosporin
US10632157B2 (en) 2016-04-15 2020-04-28 Ascus Biosciences, Inc. Microbial compositions and methods of use for improving fowl production
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
MX388995B (es) 2015-06-25 2025-03-20 Native Microbials Inc Métodos, aparatos y sistemas para analizar cepas de microorganismos de comunidades heterogéneas complejas, predecir e indentificar sus relaciones funcionales e interacciones y seleccionar y sintetizar conjuntos microbianos basados en estos.
WO2017120495A1 (en) 2016-01-07 2017-07-13 Ascus Biosciences, Inc. Methods for improving milk production by administration of microbial consortia
AR105111A1 (es) * 2015-06-26 2017-09-06 Advanced Bionutrition Corp Composición para administración de agentes activos a un animal
JP6889699B2 (ja) 2015-07-29 2021-06-18 アドバンスド バイオニュートリション コープ． 特定栄養用途のための安定乾燥プロバイオティクス組成物
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
CN116474004A (zh) 2016-04-15 2023-07-25 原生微生物股份有限公司 通过施用微生物聚生体或其纯化菌株来提高禽类的农业生产的方法
EP3471705A1 (en) * 2016-06-20 2019-04-24 Virbac Method and apparatus for preparing a micro-particles composition
JP2020503048A (ja) 2016-12-28 2020-01-30 アスカス バイオサイエンシーズ， インコーポレイテッド トレーサー分析論による複雑な不均一コミュニティの微生物株の解析、その機能的関連性及び相互作用の決定、ならびに微生物アンサンブル（投与される微生物アンサンブル及び接種される微生物アンサンブルを含む）の合成、のための方法、装置、及びシステム
CN110366596A (zh) 2016-12-28 2019-10-22 埃斯库斯生物科技股份公司 用于对复杂异质群落中的完整微生物株系进行分析、确定其功能关系及相互作用以及基于此来识别和合成生物活性改性剂的方法、设备和系统
US11044924B2 (en) 2017-04-28 2021-06-29 Native Microbials, Inc. Methods for supporting grain intensive and or energy intensive diets in ruminants by administration of a synthetic bioensemble of microbes or purified strains therefor
CN111970933A (zh) 2017-10-18 2020-11-20 埃斯库斯生物科技股份公司 通过施用微生物或其纯化菌株的合成生物集合体来提高禽类产量
WO2021163212A1 (en) 2020-02-10 2021-08-19 Native Microbials, Inc. Microbial compositions and methods of use for canine enteropathy and dysbiosis
CN116083240B (zh) * 2023-04-07 2023-08-29 深圳市第二人民医院(深圳市转化医学研究院) 工程化细菌及其制备方法和应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM572294A0 (en) 1994-05-18 1994-06-09 Vaccine Technologies Pty. Ltd. Delivery vehicle for bioactive molecule
US6485950B1 (en) * 2000-07-14 2002-11-26 Council Of Scientific And Industrial Research Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
AU2002239279A1 (en) * 2000-11-20 2002-06-03 Pr Pharmaceuticals, Inc. Oral nanosphere delivery
EP1381345B1 (en) 2001-03-23 2008-07-09 Advanced Bionutrition Corporation Delivery of disease control in aquaculture using yeasts containing bioactive proteins
MXPA04001660A (es) * 2001-08-27 2004-11-22 Advanced Bionutrition Corp Suministro para el control de enfermedad en acuacultura y agricultura usando alimentos nutritivos que contienen proteinas bioactivas producidas por virus.
US7550647B2 (en) * 2001-09-14 2009-06-23 Advanced Bionutrition Transfected shrimp as production systems for therapeutic proteins
EP1515616A4 (en) * 2002-03-19 2005-12-28 Advanced Bionutrition Corp ARACHIDOIC ACID-CONTAINING MICRO-ALPINE FEED, THEIR PREPARATION AND THEIR USE
WO2003089579A2 (en) 2002-04-15 2003-10-30 Advanced Bionutrition Corporation Incorporation of anaerobic bacteria in feed formulation
WO2003086454A1 (en) * 2002-04-18 2003-10-23 Akzo Nobel N.V. Antigen-loaded chitosan microparticles for oral vaccination
AU2003239484A1 (en) * 2002-06-11 2003-12-22 Advanced Bionutrition Corporation Zooplankton enrichment with probionts and prebionts and uses thereof
CA2490866A1 (en) * 2002-06-26 2004-01-08 Advanced Bionutrition Corporation Viruses and virus-like particles for multiple antigen and target display
WO2004025263A2 (en) * 2002-09-16 2004-03-25 Advanced Bionutrition Corporation Protein and peptide expression for passive immunity
WO2004036982A2 (en) * 2002-10-24 2004-05-06 Advanced Bionutrition Corporation Shrimp and the production thereof
WO2004043140A2 (en) * 2002-11-07 2004-05-27 Advanced Bionutrition Corp. Nutraceuticals and method of feeding aquatic animals
WO2004043139A2 (en) 2002-11-14 2004-05-27 Advanced Bionutrition Corp. Feed suitable for culturing rotifers, larval shrimp, and marine filter feeders
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
EP1619960A4 (en) * 2003-03-07 2009-03-18 Advanced Bionutrition Corp FEED FORMULATION FOR LAND AND WATER RESIDENTS
WO2005017134A2 (en) * 2003-08-19 2005-02-24 Council Of Scientific And Industrial Research Isozyme of autoclavable superoxide dismutase (sod) derived from curcuma longa l
CN1946733A (zh) * 2004-02-06 2007-04-11 高级生物营养公司 以rna介导的干扰来控制陆生和水产养殖动物疾病
US20040224019A1 (en) * 2004-03-03 2004-11-11 Adi Shefer Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs
US7973148B2 (en) * 2004-04-15 2011-07-05 Advanced Bionutrition Corporation Crustacean expression vector
WO2005115341A2 (en) * 2004-05-27 2005-12-08 Advanced Bionutrition Corporation Microparticles for oral delivery
US9492400B2 (en) * 2004-11-04 2016-11-15 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
WO2006122299A2 (en) 2005-05-11 2006-11-16 Advanced Bionutrition Corporation Fish oil in stabilized form
US7956031B2 (en) * 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
US20080286375A1 (en) 2005-11-15 2008-11-20 Amorepacific Corporation Method for Preparing Sustained-Release Microparticles Comprising Sucrose Acetate Isobutyrate
CA2638900A1 (en) * 2005-12-21 2007-07-05 Advanced Bionutrition Corporation Non-invasive detection of fish viruses by real-time pcr
US8097245B2 (en) * 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
WO2007084500A2 (en) * 2006-01-13 2007-07-26 Advanced Bionutrition Corporation Continuous spray-capture production system
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
AU2007235419A1 (en) 2006-04-03 2007-10-18 Advanced Bionutrition Corporation Feed formulations containing docosahexaenoic acid
JP2010509363A (ja) * 2006-11-08 2010-03-25 ノババックス，インコーポレイテッド 固体剤形の多相医薬組成物の製造方法
US8460726B2 (en) 2006-12-18 2013-06-11 Advanced Bionutrition Corporation Dry food product containing live probiotic
CA2673355A1 (en) 2006-12-20 2008-11-20 Advanced Bionutrition Corporation Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
US20080305096A1 (en) * 2007-06-07 2008-12-11 Unicity International, Inc. Method and composition for providing controlled delivery of biologically active substances
PL2105129T3 (pl) * 2008-03-24 2018-04-30 Intervet International B.V. Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt
WO2010042555A2 (en) * 2008-10-06 2010-04-15 The Brigham And Women's Hospital, Inc. Particles with multiple functionalized surface domains
EP2410879B8 (en) * 2009-03-26 2019-08-14 Advanced BioNutrition Corp. Microencapsulation of bioactive substances and methods of making the same
WO2010111565A2 (en) * 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
WO2012021783A2 (en) * 2010-08-13 2012-02-16 Advanced Bionutrition Corporation Dry storage stabilizing composition for biological materials

Also Published As

Publication number Publication date
US20110293657A1 (en) 2011-12-01
US8329209B2 (en) 2012-12-11
NO2105129T3 (pl) 2018-06-16
CA2659917A1 (en) 2009-09-24
ES2661038T3 (es) 2018-03-27
EP2105129A3 (en) 2011-04-27
US20090238845A1 (en) 2009-09-24
EP2105129A2 (en) 2009-09-30
US7998502B2 (en) 2011-08-16
EP2105129B1 (en) 2018-01-17
CA2659917C (en) 2012-07-17

Similar Documents

Publication Publication Date Title
PL2105129T3 (pl) Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt
IL194387A0 (en) Methods and compositions for vaccination of poultry
SI2019680T1 (sl) Poviĺ anje titra za cepljenje pri ĺ˝ivalih
ZA200802892B (en) Vaccines and methods to treat canine influenza
ZA201107285B (en) Microencapsulated bioactive agents for oral delivery and methods of the thereof
SI2461833T1 (sl) Vakcinski sestavek, ki obsega 5'-cap modificirano RNA
HUE040019T2 (hu) Hajnövekedést stimuláló készítmények és módszerek
EP2244720A4 (en) POLYPEPTIDE VACCINE AND VACCINE STRATEGY AGAINST MYCOBACTERIUM
ZA200906387B (en) Compositions and methods for enhancing the development of growing animals
PL2424621T3 (pl) Sposoby poprawy smaku i kompozycji do higieny jamy ustnej o ulepszonym smaku
ZA200904756B (en) Methods of vaccine administration
IL208241A0 (en) Heat shock protein gp96 vaccination and methods of using same
IL211670A (en) Preparations containing therapeutic antibodies against steap-1
ZA201201714B (en) Protein matrix vaccines of improved immunogenicity
EP2133092A4 (en) ORAL VACCINE
EP2453886A4 (en) PHARMACEUTICAL PRODUCT FOR ORAL ADMINISTRATION COMPRISING MGBG AND METHODS OF TREATING DISEASE
EP2773317A4 (en) COMPOSITIONS FOR IMPROVING THE ORAL HEALTH OF ANIMALS, METHOD FOR THEIR USE AND PET FOOD THEREFOR
ZA201103031B (en) Vaccine against african horse sickness virus
ZA201005149B (en) Method of increasing the milk and/or meat quantity of silage-fed animals
FR2952382B1 (fr) Vaccins et diagnostics contre les trypanosomoses animales africaines
IL198897A0 (en) Canine leishmania vaccine
EP2454374A4 (en) ORAL VACCINES PRODUCED AND ADMINISTERED WITH AN EDIBLE MICROORGANISM
GB2493662B (en) Salmonid alphavirus vaccine
EP2482843A4 (en) PROCESS FOR IMPROVED VACCINE IMMUNOGENICITY
GB0811616D0 (en) Dental constructs and methods for their preparation